BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McLaughlin SA, Brunelle CL, Taghian A. Breast Cancer-Related Lymphedema: Risk Factors, Screening, Management, and the Impact of Locoregional Treatment. J Clin Oncol 2020;38:2341-50. [PMID: 32442064 DOI: 10.1200/JCO.19.02896] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Cathcart-rake EJ, Ruddy KJ. Evidence-Based Guidance for Breast Cancer Survivorship. Hematology/Oncology Clinics of North America 2023;37:225-243. [DOI: 10.1016/j.hoc.2022.08.019] [Reference Citation Analysis]
2 Bartels SA, Donker M, Poncet C, Sauvé N, Straver ME, van de Velde CJ, Mansel RE, Blanken C, Orzalesi L, Klinkenbijl JH, van der Mijle HC, Nieuwenhuijzen GA, Veltkamp SC, van Dalen T, Marinelli A, Rijna H, Snoj M, Bundred NJ, Merkus JW, Belkacemi Y, Petignat P, Schinagl DA, Coens C, van Tienhoven G, van Duijnhoven F, Rutgers EJ. Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial. JCO 2022. [DOI: 10.1200/jco.22.01565] [Reference Citation Analysis]
3 Zheng S, Chen C, Qi W, Cai G, Xu C, Cai R, Qian X, Shen K, Cao L, Chen J. The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients.. [DOI: 10.21203/rs.3.rs-2168836/v1] [Reference Citation Analysis]
4 Gennaro M, Maccauro M, Mariani L, Listorti C, Sigari C, De Vivo A, Chisari M, Maugeri I, Lorenzoni A, Aliberti G, Scaperrotta GP, Caraceni A, Pruneri G, Folli S. Occurrence of breast-cancer-related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two-arm randomized clinical trial. Cancer 2022. [PMID: 36259883 DOI: 10.1002/cncr.34498] [Reference Citation Analysis]
5 Thalji SZ, Cortina CS, Guo MS, Kong AL. Postoperative Complications from Breast and Axillary Surgery. Surgical Clinics of North America 2022. [DOI: 10.1016/j.suc.2022.08.007] [Reference Citation Analysis]
6 Aguilera-Eguía RA, Seron P, Gutiérrez-Arias R, Zaror C. Which physical therapy intervention is most effective in reducing secondary lymphoedema associated with breast cancer? Protocol for a systematic review and network meta-analysis. BMJ Open 2022;12:e065045. [PMID: 36167383 DOI: 10.1136/bmjopen-2022-065045] [Reference Citation Analysis]
7 Zhuang L, Chen H, Zheng X, Wu S, Yu Y, Lan L, Xu L, Xu J, Fan H. Bioelectrical impedance analysis for early screening of upper limb subclinical lymphedema: A case–control study. PLoS ONE 2022;17:e0274570. [DOI: 10.1371/journal.pone.0274570] [Reference Citation Analysis]
8 Klugman M, Tringale KR, Patil S, Montagna G, Finik J, Kuo T, Eberle C, Pinkhasov A, Gillis T, Gany F, Blinder V. Lymphedema therapy referral is associated with improved understanding of lymphedema prevention among breast cancer survivors.. [DOI: 10.21203/rs.3.rs-1941994/v1] [Reference Citation Analysis]
9 Koelmeyer LA, Gaitatzis K, Dietrich MS, Shah CS, Boyages J, McLaughlin SA, Taback B, Stolldorf DP, Elder E, Hughes TM, French JR, Ngui N, Hsu JM, Moore A, Ridner SH. Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with intervention. Cancer 2022. [PMID: 35797441 DOI: 10.1002/cncr.34377] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hyland CJ, Manrique OJ, Weiss A, Broyles JM. Preventive strategies for breast cancer-related lymphedema: Working toward optimal patient selection. Cancer 2022. [PMID: 35797438 DOI: 10.1002/cncr.34374] [Reference Citation Analysis]
11 Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, Kramer J, Siegel RL. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin 2022. [PMID: 35736631 DOI: 10.3322/caac.21731] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 34.0] [Reference Citation Analysis]
12 Wang N, Gu Y, Li L, Chi J, Liu X, Xiong Y, Zhong C. Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes for Breast Cancer. J Inflamm Res 2022;15:3477-99. [PMID: 35726216 DOI: 10.2147/JIR.S357144] [Reference Citation Analysis]
13 Montagna G, Zhang J, Sevilimedu V, Charyn J, Abbate K, Gomez EA, Mehrara B, Morrow M, Barrio AV. Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer-Related Lymphedema. JAMA Oncol 2022. [PMID: 35679026 DOI: 10.1001/jamaoncol.2022.1628] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Ramírez-Parada K, Lopez-Garzon M, Sanchez-Rojel C, Petric-Guajardo M, Alfaro-Barra M, Fernández-Verdejo R, Reyes-Ponce A, Merino-Pereira G, Cantarero-Villanueva I. Effect of Supervised Resistance Training on Arm Volume, Quality of Life and Physical Perfomance Among Women at High Risk for Breast Cancer-Related Lymphedema: A Study Protocol for a Randomized Controlled Trial (STRONG-B). Front Oncol 2022;12:850564. [PMID: 35299753 DOI: 10.3389/fonc.2022.850564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Fuse Y, Karakawa R, Yano T, Yoshimatsu H. Lymph-Venous Anastomosis for Breast Cancer-Related Lymphoedema after Docetaxel-Based Chemotherapy. JCM 2022;11:1409. [DOI: 10.3390/jcm11051409] [Reference Citation Analysis]
16 Byun HK, Kim JS, Chang JS, Cho Y, Ahn SJ, Yoon JH, Kim H, Kim N, Choi E, Park H, Kim K, Park SH, Rim CH, Choi HS, Oh YK, Lee IJ, Shin KH, Kim YB. Validation of a nomogram for predicting the risk of lymphedema following contemporary treatment for breast cancer: a large multi-institutional study (KROG 20-05). Breast Cancer Res Treat 2022. [PMID: 35107713 DOI: 10.1007/s10549-021-06507-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Rafn BS, Christensen J, Larsen A, Bloomquist K. Prospective Surveillance for Breast Cancer-Related Arm Lymphedema: A Systematic Review and Meta-Analysis. J Clin Oncol 2022;:JCO2101681. [PMID: 35077194 DOI: 10.1200/JCO.21.01681] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
18 He P, Zhang B, Shen S. Effects of Out-of-Hospital Continuous Nursing on Postoperative Breast Cancer Patients by Medical Big Data. J Healthc Eng 2022;2022:9506915. [PMID: 35035864 DOI: 10.1155/2022/9506915] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Stout NL, Armer JM. Lymphedema Prospective Surveillance and Risk Reduction. Multimodal Management of Upper and Lower Extremity Lymphedema 2022. [DOI: 10.1007/978-3-030-93039-4_4] [Reference Citation Analysis]
20 Shanbehzadeh M, Kazemi-arpanahi H, Bolbolian Ghalibaf M, Orooji A. Performance evaluation of machine learning for breast cancer diagnosis: A case study. Informatics in Medicine Unlocked 2022;31:101009. [DOI: 10.1016/j.imu.2022.101009] [Reference Citation Analysis]
21 Durán-aguilar G, Rossa-sierra A, Fuentes-aguilar RQ. Design of an Auxiliary Artificial Lymphatic Vessel in Treatment of Secondary Lymphedema Due to Breast Cancer. Healthcare 2022;10:68. [DOI: 10.3390/healthcare10010068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Tsai YL, I TJ, Chuang YC, Cheng YY, Lee YC. Extracorporeal Shock Wave Therapy Combined with Complex Decongestive Therapy in Patients with Breast Cancer-Related Lymphedema: A Systemic Review and Meta-Analysis. J Clin Med 2021;10:5970. [PMID: 34945266 DOI: 10.3390/jcm10245970] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Boucheron P, Anele A, Zietsman A, Galukande M, Parham G, Pinder LF, Andersson TM, Anderson BO, Foerster M, Schüz J, Dos Santos Silva I, McCormack V. Self-reported arm and shoulder problems in breast cancer survivors in Sub-Saharan Africa: the African Breast Cancer-Disparities in Outcomes cohort study. Breast Cancer Res 2021;23:109. [PMID: 34819118 DOI: 10.1186/s13058-021-01486-9] [Reference Citation Analysis]
24 Chang PJ, Asher A, Smith SR. A Targeted Approach to Post-Mastectomy Pain and Persistent Pain following Breast Cancer Treatment. Cancers (Basel) 2021;13:5191. [PMID: 34680339 DOI: 10.3390/cancers13205191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Fabro EAN, Macedo FO, Costa RM, Lou MBDA, Marchito LDO, Aguiar SSD, Bergmann A. Guidelines for the prevention of secondary lymphedema following breast cancer treatment: adhesion and associated factors. Mastology 2021;31. [DOI: 10.29289/2594539420210035] [Reference Citation Analysis]
26 Smith BD, Mittendorf EA, Haffty BG. Multidisciplinary Locoregional Management of Breast Cancer. JCO 2020;38:2217-2219. [DOI: 10.1200/jco.20.00483] [Reference Citation Analysis]